Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
PRNewswire - November 20, 2003
It was previously announced that the first set of live testing in medical clinics in Florida had been completed with 100% accuracy. These results will be used in all filings with regulatory agencies in the United States. The live testing was based on a statistically significant and meaningful sample size and showed that the VScan HIV 1&2 Rapid test kit had 100% Sensitivity and 100% Specificity. Sensitivity is the repetition of a positive result in individuals with the disease being tested for and Specificity indicates that the individual does not have the disease.
The live testing was carried out in conjunction with the research protocol that was unanimously approved by the Independent Investigational Review Board (IRB). The IRB is an institutional review committee structured in compliance with the regulations of the U.S. Food and Drug Administration (FDA). The live testing and the results achieved are of prime importance to the Company's efforts to seek regulatory approval for the VScan HIV 1&2 rapid test kit in the United States.
About VScan
The VScan rapid test kit is a single use, disposable, accurate (greater than 99%), cost effective, easy to use, test for rapid screening of HIV 1&2 and subgroup O, Hepatitis B&C, Tuberculosis(TB). The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition, and other factors described in Company reports and other filings with regulatory bodies
SOURCE Medical Services International Inc.
Web Site: http://www.medicalservicesintl.com
031120
PR031144
Copyright © 2003 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .